JIJI JAMES: Open Payments
NPI 1154810257 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,249 in 30 payments from 10 companies in 2025. Trend: 2023 $784 · 2024 $1,171 · 2025 $1,249
Food & beverage: $1,044Education: $205
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 5 | $279 |
| Lilly USA, LLC | 4 | $181 |
| SOBI, INC | 5 | $178 |
| Incyte Corporation | 6 | $172 |
| Teleflex LLC | 1 | $154 |
| Syndax Pharmaceuticals, Inc. | 4 | $131 |
| ABBVIE INC. | 2 | $66 |
| AstraZeneca Pharmaceuticals LP | 1 | $32 |
| Celgene Corporation | 1 | $31 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
Products named: Xospata, JAKAFI, ARROW, Vonjo, JAYPIRCA, EPKINLY, Cresemba, CALQUENCE.
Industry payments across TX — which companies pay providers there.
